BIIB has been in the news 321% more than usual
Aug 14, 2025, 6:31 PM
1.02%
What does BIIB do
Biogen, headquartered in Cambridge, Massachusetts, specializes in therapies for neurological diseases, employing 7,570 people and offering treatments for conditions like MS, SMA, Alzheimer's, and ALS. Their product portfolio includes TECFIDERA, SPINRAZA, and collaborations on LEQEMBI and others.
BIIB has been in the news recently: Biogen Inc. CEO Chris Viehbacher expressed that a successful Alzheimer's trial by Novo Nordisk A/S could lead to improved combination therapies. Additionally, analysts' ratings for Biogen (BIIB) last quarter varied widely, reflecting differing opinions among ten analysts.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.